] i ) in glomus cells, the primary oxygensensing cells, is an essential step for carotid body activation by hypoxia. In the present study, we examined the effects of CIH on the glomus cell [Ca 2ϩ ] i response to hypoxia and assessed the underlying mechanisms. Glomus cells were harvested from adult rats or wild-type mice treated with 10 days of either room air (control) or CIH (alternating cycles of 15 s of hypoxia and 5 min of room air; 9 episodes/h; 8 h/day). CIH-treated glomus cells exhibited an enhanced [Ca 2ϩ ] i response to hypoxia, and this effect was absent in the presence of 2-(4-cyclopropylphenyl)-N-((1R)-1-[5-[(2,2,2-trifluoroethyl)oxo]-pyridin-2-yl]ethyl)acetamide (TTA-A2), a specific inhibitor of T-type Ca 2ϩ channels, and in voltage-gated calcium channel, type 3.2 (CaV3.2), null glomus cells. CaV3.2 knockout mice exhibited an absence of CIH-induced hypersensitivity of the carotid body. CIH increased reactive oxygen species (ROS) levels in glomus cells. A ROS scavenger prevented the exaggerated TTA-A2-sensitive [Ca 2ϩ ] i response to hypoxia. CIH had no effect on CaV3.2 mRNA levels. CIH augmented Ca 2ϩ currents and increased CaV3.2 protein in plasma membrane fractions of human embryonic kidney-293 cells stably expressing CaV3.2, and either a ROS scavenger or brefeldin-A, an inhibitor of protein trafficking, prevented these effects. These findings suggest that CIH leads to an augmented Ca 2ϩ influx via ROSdependent facilitation of CaV3.2 protein trafficking to the plasma membrane. sleep apnea; voltage-gated Ca 2ϩ channels; hypertension; protein trafficking; oxidative stress SLEEP-DISORDERED BREATHING with recurrent apnea is a major clinical problem affecting an estimated 9% of adult women and 24% of adult men in the United States (Young et al.